UW Alzheimer’s researchers provide key data for FDA-approved brain imaging agent
A brain imaging marker used for years by researchers at the University of Wisconsin School of Medicine and Public Health is moving from research settings to broader clinical use following recent Food and Drug Administration approval, marking an important step in how Alzheimer’s disease is evaluated in patients.








